Delivery Order SPE2DB20D9103-SPE2DB23FE7F5
Award Date 9/26/23
Potential Completion Date 10/18/23
Potential Value $1.5K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency, a combat support agency within the Department of Defense, awarded a firm fixed price delivery order valued at thirty-seven thousand one hundred thirty-seven dollars and sixty cents ($37,137.60) to DMS Pharmaceutical Group Incorporated. The order is for Xolair 150 mg/ml syringes to be delivered to a location in Park Ridge, Illinois between August 22, 2023 and September 13, 2023. No major subcontractors or set aside designations were indicated. The Defense Logistics...
- The Defense Logistics Agency, a combat logistics support agency within the Department of Defense, awarded a $9,284 delivery order contract to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. Under the firm fixed price delivery order, DMS Pharmaceutical will provide 150 mg/ml syringes of Xolair, a medication used to treat allergic asthma and chronic idiopathic urticaria. Performance will take place in Park Ridge, Illinois over a three-week period concluding on September 22, 2023. No...
- The Defense Logistics Agency (DOD) awarded a $77,370 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for XOLAIR 150 MG/ML SYRINGEML. The place of performance is Park Ridge, Illinois. The period of performance is from September 5, 2023 through September 26, 2023. As the DLA supports the logistical needs of the military services, this delivery order is likely providing a pharmaceutical product in support of DOD medical readiness programs over the three week period of...
- The Defense Logistics Agency, a combat support agency within the Department of Defense, awarded a $46,513.20 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for the product "XOLAIR 150 MG/ML SYRINGEML." The place of performance will be in Park Ridge, Illinois, and the period of performance is from September 29, 2023 through October 23, 2023. As the DLA supports military operations by providing food, fuel, repair parts and other supplies, this delivery order is likely...
- The Defense Logistics Agency awarded a $3,094.80 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for the purchase of Xolair 150 MG/ML syringes. The contract has a period of performance from September 19, 2023 through October 11, 2023 and will be performed in Park Ridge, Illinois. The Defense Logistics Agency manages the Department of Defense's global logistics network and supply chain, and this delivery order is likely associated with the agency's medical supply procurement...
- The Defense Logistics Agency awarded a $46,422 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply Xolair 150 mg/ml syringes. The contract has a period of performance from August 2nd to August 23rd, 2023, with all work to be conducted in Park Ridge, Illinois. DLA is the Department of Defense's combat logistics support agency, managing the global supply chain for the military's medical supplies. This delivery order falls under DLA's portfolio to ensure troops have access to...
- The Defense Logistics Agency awarded a $6,189.60 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for the product "XOLAIR 150 MG/ML SYRINGEML." The place of performance will be in Park Ridge, Illinois, with work scheduled to be completed between June 28, 2023 and July 20, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics network and supply chain, and this delivery order was likely placed to supply the product to DOD customers and...
- The Defense Logistics Agency (DOD) awarded a $1,547 delivery order to DMS Pharmaceutical Group Inc. for Xolair 150 mg/ml syringes. The firm fixed price order is for product delivery to a location in Park Ridge, Illinois between July 24 and August 14, 2023. DLA supports military readiness by procuring and providing medical supplies to the armed forces. This small order for an epinephrine drug will help ensure service members have access to necessary pharmaceuticals. No subcontractors or set aside...
- The Defense Logistics Agency, a component of the Department of Defense, awarded a $6,189.60 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for the provision of 4562180530 XOLAIR 150 MG/ML SYRINGEML. The place of performance will be Park Ridge, Illinois from September 13, 2023 through October 4, 2023. No major subcontractors or set aside designations were identified. The Defense Logistics Agency manages the global supply chain for the United States military and supports its...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at approximately $2,321 to DMS Pharmaceutical Group Inc. for the provision of 75 mg/0.5 ml syringes of Xolair. The place of performance is Park Ridge, Illinois and the period of performance spans from July 28, 2023 through August 18, 2023. No subcontractors or set aside designations were indicated. The Defense Logistics Agency supports Department of Defense health care programs by procuring...
- SPE2DB20D9103Indefinite Delivery Contract
- SPE2DB20D9103-SPE2DB23FE7F5Delivery Order
The Defense Logistics Agency, a combat logistics support agency within the Department of Defense, awarded a $1,547 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for the provision of 150 mg/ml Xolair syringes. The place of performance is Park Ridge, Illinois and the period of performance is September 26, 2023 through October 18, 2023. No subcontractors or set aside designations were identified. The delivery order was issued against an existing DLA pharmaceuticals contract vehicle to supply an epinephrine product used to treat allergic conditions, with the short period of performance indicating an urgent requirement.
Generated 12/26/23, 9:32 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 9/26/23 |